Further, they showed that TET2 and IDH mutations are mutually exclusive in AML, result in overlapping methylation signatures, and impair HSC differentiation in 32D myeloid cells (Figueroa et al., 2010). The gene discussed is TET2; the disease is acute myeloid leukemia.